产品中心Cell Resources
联系我们CONTACT US
400-999-210024小时服务热线
产品概述
| 名称 | HPAC (人胰腺腺泡上皮癌) (STR鉴定正确) |
| 别称 | Hpac |
| 种属 | 人 |
| 生长特性 | 贴壁细胞 |
| 细胞形态 | 上皮细胞样 |
| 冻存条件 | 冻存液：55% 基础培养基+40%FBS+5%DMSO 温度：液氮 |
| 培养方案A（默认） |
生长培养基:
培养条件:
气相：空气，95%；CO2，5%, 温度：37℃
|
| 推荐传代比例 | 1:3-1:6 |
| 推荐换液频率 | 2-3次/周 |
| 年龄（性别） | 女性；64岁 |
| 组织来源 | 胰腺 |
| 细胞类型 | 肿瘤细胞 |
| 肿瘤类型 | 胰腺癌细胞 |
| 生物安全等级 | BSL-1 |
| 倍增时间 | ~23-44 hours |
| 致瘤性 | Yes, the cells form tumors in athymic nude mice at the site of inoculation which are histologically similar to the tumor of origin.Yes, the cells have a colony forming efficiency of 64% on plastic and 3.2% in agarose. |
| 受体表达情况 | epidermal growth factor (EGF), expressed;glucocorticoid, expressed;epidermal growth factor (EGF); glucocorticoid |
| 基因表达情况 | HPAC cells are positive for keratin and negative for vimentin and chromogranin A. |
| 保藏机构 | ATCC; CRL-2119 |
STR鉴定
-
STR位点信息
Amelogenin X CSF1PO 13 D2S1338 19,23 D3S1358 15,17 D5S818 12 D7S820 10,12 D8S1179 12,14 D13S317 11 D16S539 9,10 D18S51 16 D19S433 14 D21S11 30 FGA 24 PentaD 13 PentaE 15,17 TH01 9.3 TPOX 10,11 vWA 15,17 D6S1043 18 D12S391 17,18 D2S441 11,14 -
STR鉴定图
-
参考文献
-
Overcoming the On-Target Toxicity in Antibody-Mediated Therapies via an Indirect Active Targeting Strategy (2023-01-22)
作者：Zhongjie Tang:1.Medical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, P. R. China. ; Xiaoyou Wang:1.Medical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, P. R. China. ; Mei Tang:1.Medical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, P. R. China. ; Jin Wu:1.Department of Breast and Thyroid Surgery, Southwest Hospital, Chongqing, 400038, P. R. China. ; Jiexuan Zhang:1.Medical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, P. R. China. ; Xinlong Liu:1.Medical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, P. R. China. ; Feiyan Gao:1.Medical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, P. R. China. ; Yu Fu:1.Medical Research Institute, College of Pharmaceutical Sciences, Southwest U
期刊：Overcoming the On-Target Toxicity in Antibody-Mediated Therapies via an Indirect Active Targeting Strategy
影响因子 ：15.1
引用产品： 4T1 细胞 , MCF7 [MCF-7] 细胞 , A549 [A-549] 细胞 , A20 细胞 , RM-1 细胞 , NCI-N87 [N87] 细胞 , TE-1 细胞 , P388D1 细胞 , HPAC 细胞
FAQs
Q：{{item.question}}
A：
产品资料
识别码示意图
![KATO III [KATO 3] (人胃癌细胞) (STR鉴定正确)](/Public/upfile/pic/xbx/CL-0372-1.jpg)
![MGC80-3 [MGC-803] (人胃癌细胞) (Hela污染细胞系，暂不供应)](/Public/upfile/pic/xbx/CL-0158-1.jpg)
